RBC8
| CAS No. | 361185-42-4 | Cat. No. | BCP16843 |
| Name | RBC8 | ||
| Synonyms | RBC-8;RBC 8; | ||
| Formula | C25H20N4O3 | M. Wt | 424.45 |
| Description | RBC8 or BQU57 treatment showed no further inhibition of colony formation after Ral knockdown. RBC8 and BQU57 showed favorable properties that define good drug candidates. To test the effect of Ral inhibitors on xenograft tumor growth, nude mice were inoculated subcutaneously with H2122 human lung cancer cells and treated intraperitoneally with 50 mg/kg/d of RBC8 for 21 days (except weekends). RBC8 inhibited tumor growth to a similar extent as dual knockdown of RalA and RalB. | ||
| Pathways | Ion Channel/Membrane Transporter GPCR/G Protein | ||
| Targets | Ras/Rho ATPase | ||
Structure
Part data of this page collected from the open network resources, so Biochempartner can not guarantee its accuracy.
For product details of different batches, please contact our Customer
- Service & Tech Support:orders@biochempartner.com
- Website:www.biochempartner.com
Products are for research use only and not for human use. We do not sell to patients.